CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Mar. 31, 2018
Dec. 31, 2017
Mar. 31, 2017
Operating activities:            
Net income $ 61,022 $ 71,655        
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization 90,383 93,931        
Debt premium and discount amortization (952) (1,684)        
Deferred financing cost amortization 1,682 1,800        
Above- and below-market lease intangible amortization (6,824) (7,796)        
Provisions for impairment 15,902 5,686        
Gain on disposition of operating properties (11,448) (8,805)        
Equity based compensation 2,484 2,126        
Other 824 344        
Loss on extinguishment of debt 132 1,262        
Changes in operating assets and liabilities:            
Receivables 12,171 (3,593)        
Deferred charges and prepaid expenses (5,309) (12,321)        
Other assets 40 (274)        
Accounts payable, accrued expenses and other liabilities (35,657) (34,181)        
Net cash provided by operating activities 124,450 108,150        
Investing activities:            
Improvements to and investments in real estate assets (76,803) (39,260)        
Acquisitions of real estate assets 0 (104,811)        
Proceeds from sales of real estate assets 104,198 34,091        
Purchase of marketable securities (3,655) (7,502)        
Proceeds from sale of marketable securities 4,496 8,335        
Net cash provided by (used in) investing activities 28,236 (109,147)        
Financing activities:            
Repayment of secured debt obligations (4,858) (5,961)        
Repayment of borrowings under unsecured revolving credit facility 0 (57,000)        
Proceeds from borrowings under unsecured revolving credit facility 0 145,000        
Proceeds from unsecured notes 0 396,036        
Repayment of borrowings under unsecured term loan (50,000) (390,000)        
Deferred financing costs (184) (3,508)        
Distributions to common stockholders (84,165) (79,493)        
Distributions to non-controlling interests 0 (101)        
Repurchases of common shares (29,765) 0        
Repurchases of common shares in conjunction with equity award plans (1,722) (2,463)        
Net cash provided by (used in) financing activities (170,694) 2,510        
Net change in cash, cash equivalents and restricted cash (18,008) 1,513        
Cash, cash equivalents and restricted cash at beginning of period 110,777 102,869 $ 102,869      
Cash, cash equivalents and restricted cash at end of period 92,769 104,382 110,777      
Reconciliation to consolidated balance sheets            
Cash and cash equivalents 27,332 59,883 56,938      
Restricted cash       $ 65,437 $ 53,839 $ 44,499
Cash, cash equivalents and restricted cash at end of period 110,777 102,869 102,869 92,769 110,777 104,382
Supplemental disclosure of cash flow information:            
Cash paid for interest, net of amount capitalized of $654 and $946 63,646 66,815        
Brixmor Operating Partnership LP            
Operating activities:            
Net income 61,022 71,655        
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization 90,383 93,931        
Debt premium and discount amortization (952) (1,684)        
Deferred financing cost amortization 1,682 1,800        
Above- and below-market lease intangible amortization (6,824) (7,796)        
Provisions for impairment 15,902 5,686        
Gain on disposition of operating properties (11,448) (8,805)        
Equity based compensation 2,484 2,126        
Other 824 344        
Loss on extinguishment of debt 132 1,262        
Changes in operating assets and liabilities:            
Receivables 12,171 (3,593)        
Deferred charges and prepaid expenses (5,309) (12,321)        
Other assets 40 (274)        
Accounts payable, accrued expenses and other liabilities (35,657) (34,181)        
Net cash provided by operating activities 124,450 108,150        
Investing activities:            
Improvements to and investments in real estate assets (76,803) (39,260)        
Acquisitions of real estate assets 0 (104,811)        
Proceeds from sales of real estate assets 104,198 34,091        
Purchase of marketable securities (3,654) (7,502)        
Proceeds from sale of marketable securities 4,496 8,335        
Net cash provided by (used in) investing activities 28,237 (109,147)        
Financing activities:            
Repayment of secured debt obligations (4,858) (5,961)        
Repayment of borrowings under unsecured revolving credit facility 0 (57,000)        
Proceeds from borrowings under unsecured revolving credit facility 0 145,000        
Proceeds from unsecured notes 0 396,036        
Repayment of borrowings under unsecured term loan (50,000) (390,000)        
Deferred financing costs (184) (3,508)        
Partner distributions (115,652) (82,054)        
Net cash provided by (used in) financing activities (170,694) 2,513        
Net change in cash, cash equivalents and restricted cash (18,007) 1,516        
Cash, cash equivalents and restricted cash at beginning of period 110,747 102,834 102,834      
Cash, cash equivalents and restricted cash at end of period 92,740 104,350 110,747      
Reconciliation to consolidated balance sheets            
Cash and cash equivalents 27,303 59,851 56,908      
Restricted cash       65,437 53,839 44,499
Cash, cash equivalents and restricted cash at end of period $ 110,747 102,834 $ 102,834 $ 92,740 $ 110,747 $ 104,350
Supplemental disclosure of cash flow information:            
Cash paid for interest, net of amount capitalized of $654 and $946   $ 66,815